The future of hiv-1 therapeutics : resistance is futile? / edited by Bruce E. Torbett, David S. Goodsell, Douglas D. Richman.
Tipo de material:
TextoSeries Current Topics in Microbiology and Immunology ; 389Editor: Cham : Springer International Publishing : Springer, 2015Descripción: x, 254 páginasTipo de contenido: - texto
- computadora
- recurso en línea
- 9783319185187
- QR177
Contenidos:
HIV Therapy Looking Towards the Future -- Computational challenges of structure-based approaches applied to HIV -- Nucleocapsid Protein: A Desirable Target For Future Therapies Against HIV-1 -- HIV-1 integrase multimerization as a therapeutic target -- Targeting HIV transcription: The quest for a functional cure -- Targeting the HIV RNA Genome: High-Hanging Fruit Only Needs a Longer Ladder -- HIV-1 Gag: An Emerging Target for Antiretroviral Therapy -- The Triple Threat of HIV-1 Protease Inhibitors -- Illustrations of the HIV Life Cycle.
No hay ítems correspondientes a este registro
Springer eBooks
HIV Therapy Looking Towards the Future -- Computational challenges of structure-based approaches applied to HIV -- Nucleocapsid Protein: A Desirable Target For Future Therapies Against HIV-1 -- HIV-1 integrase multimerization as a therapeutic target -- Targeting HIV transcription: The quest for a functional cure -- Targeting the HIV RNA Genome: High-Hanging Fruit Only Needs a Longer Ladder -- HIV-1 Gag: An Emerging Target for Antiretroviral Therapy -- The Triple Threat of HIV-1 Protease Inhibitors -- Illustrations of the HIV Life Cycle.
Para consulta fuera de la UANL se requiere clave de acceso remoto.